<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03327584</url>
  </required_header>
  <id_info>
    <org_study_id>24623</org_study_id>
    <nct_id>NCT03327584</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Versus Landmark Guided Small &amp; Medium Joint Arthrocentesis</brief_title>
  <official_title>Ultrasound Guided Versus Landmark Guided Small &amp; Medium Joint Arthrocentesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arthrocentesis is the removal of synovial fluid for analysis of pathologic processes. Small &amp;
      medium joint arthrocentesis will be defined as the following joints: elbow, wrist, finger,
      ankle and toe. Ultrasound (US) and landmark (LM) small &amp; medium joint arthrocentesis are both
      performed within the clinical setting. Both techniques are considered standard of care.
      Selection of which technique to use is dependent upon the physician's preference. There is
      currently limited data comparing the two methods. The investigators hope to determine if one
      modality is more effective in terms of success rate, number of attempts, and time to complete
      the procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients presenting to the Emergency Department who are 18 years old or older, who do not
      belong to a vulnerable group, requiring small or medium joint arthrocentesis will be included
      in this trial. The investigators will randomize each patient into LM vs US. Data collected
      will include number of attempts to tap the joint, success rate, and time for procedure to be
      completed. The arthrocentesis will be performed by PGY-3 residents only. A 21 gauge needle
      will be used for the arthrocentesis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Superiority of Method of arthrocentesis</measure>
    <time_frame>1 day</time_frame>
    <description>Number of attempts until successful arthrocentesis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success of method</measure>
    <time_frame>1 day</time_frame>
    <description>Completion of arthrocentesis after three attempts</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Effusion Joint</condition>
  <arm_group>
    <arm_group_label>Ultrasound Guided Arthrocentesis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients in this group will have ultrasound guided arthrocentesis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Landmark Guided Arthrocentesis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients in this group will have landmark guided arthrocentesis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthrocentesis</intervention_name>
    <description>Athrocentesis</description>
    <arm_group_label>Landmark Guided Arthrocentesis</arm_group_label>
    <arm_group_label>Ultrasound Guided Arthrocentesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients who require an arthrocentesis of a small and/or medium joint (defined
             previously)

        Exclusion Criteria:

          -  Coagulopathic patients

          -  Patients on anticoagulants

          -  Patients with cellulitis overlying the joint.

          -  Patients with artificial joints

          -  Adults Unable to Consent

          -  Vulnerable Populations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryan C Gibbons, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lewis Katz School of Medicine at Temple University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lewis Katz School of Medicine at Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 27, 2017</study_first_submitted>
  <study_first_submitted_qc>October 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>January 20, 2020</last_update_submitted>
  <last_update_submitted_qc>January 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrarthrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

